FDA Inspection 1312222 — BioTissue Holdings Inc
The FDA completed an inspection of BioTissue Holdings Inc on Sep 1, 2026 in Doral, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 1, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Doral, FL (United States)